WRBY insider plans Rule 144 sale of 25,000 common shares

WRBY filed a notice that a shareholder plans to sell 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $544,750.00.

Rhea-AI Filing Summary

WRBY filed a notice that a shareholder plans to sell 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $544,750.00. The filing notes that 105,727,103 shares of this class were outstanding and the approximate sale date is 01/02/2026.

The 25,000 shares were acquired on 06/28/2017 via previously exercised options and restricted stock units, paid in cash. The document also reports prior Rule 10b5-1 activity: on 12/11/2025, 200,000 common shares were sold for gross proceeds of $6,040,800.00 for the account of David Gilboa. The signer represents they are not aware of undisclosed material adverse information about the issuer.

FAQ

What does the Form 144 filing for WRBY disclose?

It discloses that a shareholder intends to sell 25,000 common shares of the issuer on or about 01/02/2026 on the NYSE, with an aggregate market value of $544,750.00.

How many WRBY shares are planned to be sold and at what value?

The notice covers 25,000 common shares with an aggregate market value of $544,750.00, to be sold through Morgan Stanley Smith Barney LLC.

How many WRBY shares were outstanding according to this notice?

The document states that 105,727,103 shares of the relevant class were outstanding at the time referenced.

When and how were the WRBY shares being sold originally acquired?

The 25,000 shares were acquired on 06/28/2017 through previously exercised options and restricted stock units, with consideration described as cash and N/A.

What prior WRBY stock sales in the last three months are reported?

The filing lists 10b5-1 sales for David Gilboa of 200,000 common shares on 12/11/2025, generating gross proceeds of $6,040,800.00.

What representation does the seller make in this WRBY Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/02/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883353
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Warby Parker Inc.
SEC File Number	001-40825
Address of Issuer	233 Spring Street, 6th Floor East New York NEW YORK 10013
Phone	6468477215
Name of Person for Whose Account the Securities are To Be Sold	DAVID GILBOA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	544750.00	105727103	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/28/2017	Previously Exercised Options and Restricted Stock Units	Issuer			25000	06/28/2017	Cash and N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAVID GILBOA 233 Spring Street, 6th Floor East New York NY 10013	COMMON	12/11/2025	200000	6040800.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon previously exercised options and the vesting of restricted stock units during the period of 6/28/2017 through 12/31/2023
Date of Notice	01/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Abraham Gilboa
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)